Zacks Investment Research on MSN

Here's why Insulet (PODD) is a strong growth stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...
Expansion follows successful multi-year pilots in Massachusetts and California, and longstanding Pod takeback programs in Europe, Canada, and Australia Insulet Corporation (NASDAQ: PODD) (“Insulet” or ...
The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet Corporation) since its launch in 2022. Omnipod 5, the only tubing-free pump ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. An updated algorithm for the Omnipod 5 automated insulin ...
Pease announced, "For the fourth quarter, we expect total Omnipod revenue growth of 27% to 30% and total company growth of 25% to 28%." She guided for fourth quarter U.S. Omnipod growth of 24% to 27% ...
Medical devices are not particularly known for bold branding. Omnipod, an insulin pump owned by Insulet, aims to change that with its own custom color created with Pantone. Last week, the 25-year-old ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, and Pantone ®, ...
Insulet is bringing a splash of color to the diabetes technology market. Working with Pantone, the insulin pump company has created the “bright and joyful tropical orange yellow” color Omnipod Mango.
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equities ...
Aug 7 (Reuters) - Medical device maker Insulet (PODD.O), opens new tab beat Wall Street estimates for second-quarter profit and revenue on strong demand for its wearable insulin pumps, sending its ...